Mesirow Financial Investment Management Equity & Fixed Income Ligand Pharmaceuticals Inc Transaction History

Mesirow Financial Investment Management Equity & Fixed Income

$97.3 Million
Q3 2024

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 09, 2022	SELL	$94.99 - $151.56 $8.17 Million - $13 Million	-85,990 Closed	0 $0
Q4 2021 Feb 07, 2022	SELL	$127.69 - $165.85 $143,012 - $185,752	-1,120 Reduced 1.29%	85,990 $13.3 Million
Q3 2021 Nov 04, 2021	BUY	$102.33 - $144.73 $7.05 Million - $9.97 Million	68,865 Added 377.45%	87,110 $12.1 Million
Q2 2021 Aug 03, 2021	BUY	$113.03 - $155.64 $481,507 - $663,026	4,260 Added 30.46%	18,245 $2.39 Million
Q1 2021 May 03, 2021	BUY	$99.52 - $215.83 $1.39 Million - $3.02 Million	13,985 New	13,985 $2.13 Million
Q1 2019 May 13, 2019	SELL	$105.93 - $142.47 $6.64 Million - $8.93 Million	-62,671 Closed	0 $0
Q4 2018 Feb 05, 2019	BUY	$128.36 - $272.13 $2.11 Million - $4.48 Million	16,454 Added 35.6%	62,671 $8.5 Million
Q3 2018 Oct 29, 2018	SELL	$211.18 - $274.49 $6.55 Million - $8.52 Million	-31,030 Reduced 40.17%	46,217 $12.7 Million
Q2 2018 Aug 02, 2018	SELL	$150.77 - $207.98 $1.12 Million - $1.54 Million	-7,405 Reduced 8.75%	77,247 $16 Million
Q1 2018 May 09, 2018	SELL	$138.63 - $182.62 $3.08 Million - $4.06 Million	-22,235 Reduced 20.8%	84,652 $14 Million
Q4 2017 Jan 30, 2018	SELL	$128.36 - $147.04 $4.46 Million - $5.11 Million	-34,739 Reduced 24.53%	106,887 $14.6 Million
Q3 2017 Oct 30, 2017	BUY	$120.91 - $137.94 $17.1 Million - $19.5 Million	141,626	141,626 $19.3 Million

Others Institutions Holding LGND

# of Institutions

256

Shares Held

18.1M

Call Options Held

26.8K

Put Options Held

9.3K

View Full List

About LIGAND PHARMACEUTICALS INC

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.94B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

More about LGND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mesirow Financial Investment Management Equity & Fixed Income, based on Form 13F filings with the SEC.

News

Stay updated on Mesirow Financial Investment Management Equity & Fixed Income with notifications on news.

Account